XML 13 R4.htm IDEA: XBRL DOCUMENT v3.21.4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) - USD ($)
shares in Thousands
3 Months Ended 6 Months Ended
Nov. 30, 2021
Nov. 30, 2020
Nov. 30, 2021
Nov. 30, 2020
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)        
Net sales, $ 9,611,000 $ 1,683,000 $ 15,257,000 $ 3,695,000
Cost of sales 5,092,000 1,306,000 8,457,000 3,091,000
Gross profit 4,519,000 377,000 6,800,000 604,000
Operating expenses:        
Selling, general and administrative 2,489,000 1,501,000 4,442,000 3,015,000
Research and development 1,313,000 820,000 2,634,000 1,720,000
Total operating expenses 3,802,000 2,321,000 7,076,000 4,735,000
Income (loss) from operations 717,000 (1,944,000) (276,000) (4,131,000)
Interest expense, net (1,000) (12,000) (10,000) (25,000)
Net gains from dissolution of Aehr Test Systems Japan 0 0 0 2,186,000
Gain from forgiveness of PPP loan 0 0 1,698,000 0
Other income (expense), net 35,000 (6,000) 58,000 (100,000)
Income (loss) before income tax (expense) benefit 751,000 (1,962,000) 1,470,000 (2,070,000)
Income tax (expense) benefit (34,000) (4,000) (57,000) 211,000
Net income (loss) $ 717,000 $ (1,966,000) $ 1,413,000 $ (1,859,000)
Net income (loss) per share        
Basic $ 0.03 $ (0.08) $ 0.06 $ (0.08)
Diluted $ 0.03 $ (0.08) $ 0.05 $ (0.08)
Shares used in per share calculations:        
Basic 26,205 23,396 25,102 23,322
Diluted 28,342 23,396 26,849 23,322